Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES
Research Laboratory, Retina Service, Massachusetts Eye
and Ear Infirmary,
Harvard Medical School, Boston, 02114, USA.
PURPOSE: The authors have previously shown that photodynamic therapy (PDT)
using lipoprotein-delivered benzoporphyrin derivative mono-acid (BPD)
effectively closed experimental choroidal neovascularization (CNV).